InMed Pharmaceuticals, Inc. is a pharmaceutical drug development company, which engages in developing small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6
Frequently Asked Questions
What is Market Cap of InMed Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. InMed Pharmaceuticals Inc market cap is $7.47M.
What is the 52-week high for InMed Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. InMed Pharmaceuticals Inc 52 week high is $2.50 as of September 21, 2026.
What is the 52-week low for InMed Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. InMed Pharmaceuticals Inc 52 week low is $0.575 as of September 21, 2026.
What is InMed Pharmaceuticals Inc stock price today?
InMed Pharmaceuticals Inc stock price today is $1.36.
What was InMed Pharmaceuticals Inc stock price yesterday?
InMed Pharmaceuticals Inc stock price yesterday was $1.39.
What is the PE ratio of InMed Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. InMed Pharmaceuticals Inc's P/E ratio is -0.44.
What is the Price-to-Book ratio of InMed Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. InMed Pharmaceuticals Inc P/B ratio is 6.7551.
What is the 50-day moving average of InMed Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. InMed Pharmaceuticals Inc 50-day moving average is $1.47.
How many employees does InMed Pharmaceuticals Inc have?